Cargando…

Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

BACKGROUND: Tuberculosis (TB) is an infectious disease. During TB, regulatory T cells (Treg) are related to poor prognosis. However, information about conventional and unconventional Treg (cTreg and uTreg, respectively) is limited. The tumour necrosis factor (TNF) and its receptors (TNFR1 and TNFR2)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Téllez-Navarrete, Norma A., Ramon-Luing, Lucero A., Muñoz-Torrico, Marcela, Preciado-García, Mario, Medina-Quero, Karen, Hernandez-Pando, Rogelio, Chavez-Galan, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278684/ https://www.ncbi.nlm.nih.gov/pubmed/34261449 http://dx.doi.org/10.1186/s10020-021-00320-4

Ejemplares similares

Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death Mechanisms
por: Ramon-Luing, Lucero A., et al.
Publicado: (2023)

Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity
por: Ocaña-Guzmán, Ranferi, et al.
Publicado: (2021)

Mycobacterium tuberculosis H37Rv Strain Increases the Frequency of CD3(+)TCR(+) Macrophages and Affects Their Phenotype, but Not Their Migration Ability
por: Ramon-Luing, Lucero A., et al.
Publicado: (2021)

Pre-Exposure of Mycobacterium tuberculosis-Infected Macrophages to Crystalline Silica Impairs Control of Bacterial Growth by Deregulating the Balance between Apoptosis and Necrosis
por: Chávez-Galán, Leslie, et al.
Publicado: (2013)

Drug hypersensitivity in drug-resistant tuberculosis
por: Katran, Zeynep Yegin, et al.
Publicado: (2023)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

Lipoarabinomannan Decreases Galectin-9 Expression and Tumor Necrosis Factor Pathway in Macrophages Favoring Mycobacterium tuberculosis Intracellular Growth
por: Chávez-Galán, Leslie, et al.
Publicado: (2017)

Treatment of drug-resistant tuberculosis
por: Pinto, Lancelot, et al.
Publicado: (2011)

Drug-resistant Spinal Tuberculosis
por: Jain, Anil K, et al.
Publicado: (2018)

Belarus and drug-resistant tuberculosis
Publicado: (2019)

Diverse Cell Death Mechanisms Are Simultaneously Activated in Macrophages Infected by Virulent Mycobacterium tuberculosis
por: Ramon-Luing, Lucero A., et al.
Publicado: (2022)

Active tuberculosis patients have high systemic IgG levels and B-cell fingerprinting, characterized by a reduced capacity to produce IFN-γ or IL-10 as a response to M.tb antigens
por: Flores-Gonzalez, Julio, et al.
Publicado: (2023)

Extensively Drug-Resistant Tuberculosis, China
por: Tang, Shenjie, et al.
Publicado: (2011)

Tuberculosis Drug Resistance Mutation Database
por: Sandgren, Andreas, et al.
Publicado: (2009)

Extensively Drug-Resistant Tuberculosis,Taiwan
por: Yu, Ming-Chih, et al.
Publicado: (2008)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

Spread of Extensively Drug-resistant Tuberculosis
por: Samper, Sofía, et al.
Publicado: (2007)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Extensive Drug Resistance in Malaria and Tuberculosis
por: Wongsrichanalai, Chansuda, et al.
Publicado: (2010)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Extensively Drug-Resistant Tuberculosis, Pakistan
por: Hasan, Rumina, et al.
Publicado: (2010)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

The road to drug resistance in Mycobacterium tuberculosis
por: Koch, Anastasia, et al.
Publicado: (2014)

Linezolid for drug‐resistant pulmonary tuberculosis
por: Singh, Bhagteshwar, et al.
Publicado: (2019)

Gender and Drug-Resistant Tuberculosis in Nigeria
por: Oladimeji, Olanrewaju, et al.
Publicado: (2023)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Profile of Nontuberculous Mycobacteria in Patients Suspected of Tuberculosis and Drug-Resistant Tuberculosis
por: Sharma, Megha, et al.
Publicado: (2020)

Antimicrobial resistance and the growing threat of drug-resistant tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2016)

Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa
por: Shah, N. Sarita, et al.
Publicado: (2011)

Bifurcation analysis of a tuberculosis progression model for drug target identification
por: Flores-Garza, Eliezer, et al.
Publicado: (2023)

Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe
por: Sagonda, Tichaona, et al.
Publicado: (2014)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!
por: Desai, Unnati, et al.
Publicado: (2019)

Drug-Resistant Mycobacterium tuberculosis among New Tuberculosis Patients, Yangon, Myanmar
por: Phyu, Sabai, et al.
Publicado: (2003)

Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia
por: Biadglegne, Fantahun, et al.
Publicado: (2014)

High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection
por: Ramon-Luing, Lucero A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_baedc5e71jfacdafml810eqb1o